ResMed Inc. (RMD) Gains Analyst Confidence as Price Targets Rise on Strong Earnings
ResMed Inc. (NYSE:RMD) is one of the best medical technology stocks to invest in. On January 30, KeyBanc Capital Markets lifted its price target on ResMed Inc.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 400,000 | $96,348,000 | -43% | 6.34% | |
| 2. | Renaissance Technologies Jim Simons | 304,480 | $73,340,098 | +425% | 0.11% |
| 3. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 273,609 | $65,904,200 | +174% | 0.04% |
| 4. | AQR Capital Management Cliff Asness | 255,884 | $61,634,645 | +16% | 0.03% |
| 5. | Ilex Capital Partners Jonas Diedrich And David Sutton | 246,006 | $59,255,465 | +165% | 1.67% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $69.13 | 2,487 | $171,926.31 | 19,216 | 2016-08-17 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $225.50 | 4,991 | $1,125,486.47 | 466,223 | 2026-04-07 | Filing | |
| $224.31 | 1,000 | $224,310.00 | 83,495 | 2026-04-01 | Filing | |
| $225.00 | 2,000 | $450,000.00 | 60,773 | 2026-04-01 | Filing | |
| $251.03 | 4,991 | $1,252,901.71 | 466,223 | 2026-03-09 | Filing | |
| $260.22 | 2,000 | $520,440.00 | 62,773 | 2026-03-04 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 119,824 | $26,898,091 | 2.17% | |
| 2. | 99,845 | $22,413,122 | 0.35% | |
| 3. | 95,011 | $21,328,069 | 0.84% | |
| 4. | 78,355 | $17,589,130 | 0.5% | |
| 5. | 66,694 | $14,971,469 | 0.41% |